Clinical Trials in New York

Showing 16881-16900 of 22,668 trials

Sunnaas International Network´s Stroke Study

NCT01732679

A descriptive study of the stroke rehabilitation content in specialized clinics in seven countries: procedures for admission to rehabilitation, services available and provided to patients, as well as duration of the stay and discharge routines. An observational study of changes in regard to the physical function, quality of life and psycho-social factors in stroke patients before and after specialized rehabilitation

Cerebral Stroke

Sunnaas Rehabilitation Hospital230 participantsStarted Sep 2012

New York, New York, United States • Chengdu, Sichuan, China • Beijing, China +6 more locations

UNKNOWN< 1 mile

Endoscopic Resection Multicenter Registry

NCT03065257

This is a retrospective and prospective multicenter registry to collect long-term data (1 year) on patients who have or will undergo Endoscopic resection such as EMR, ESD, EFTR, STER, etc. within the gastrointestinal tract for endoscopic treatment of early gastrointestinal neoplasms involving the resection of the superficial layers, mucosa and submucosa, of the tract wall. Subjects will be consented for medical chart review. The purpose of this retrospective and prospective registry is to assess long term data on efficacy, safety and clinical outcome of Endoscopic Resection within the gastrointestinal tract (1 year). The registry will evaluate efficacy, technical feasibility, clinical outcome, safety profile and overall clinical management through medical chart review. The procedures the investigators are evaluating are all clinically indicated and will not be prescribed to someone to participate in this registry study.

Gastrointestinal NeoplasmsGastrointestinal DiseaseGastric Cancer+10 more

Weill Medical College of Cornell University200 participantsStarted Mar 2017

New York, New York, United States

Sunnaas International Network´s Stroke Study

Endoscopic Resection Multicenter Registry

Find Trials by Condition in New York

A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)

Camp High 5: Evaluation of the Effect on Upper Limb Function

Efficacy of Single Injection Femoral Nerve Block With Liposomal Bupivacaine for Total Knee Arthroplasty

Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)

A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Pediatric Schizophrenia Efficacy and Safety Study

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries

ACEI/ARB Study in Ambulatory and Day of Surgery Admission Patients

Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC

Staccato Loxapine in Migraine (Out Patient)

Improving Memory in Patients With Multiple Sclerosis

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)